Refractory Mycobacterium avium complex pulmonary disease

Refractory *Mycobacterium avium* complex pulmonary disease is a chronic, non-tuberculous mycobacterial infection of the respiratory tract that persists despite standard multi-agent antimicrobial therapy Predominantly affecting adults with structural lung abnormalities—such as bronchiectasis or chronic obstructive pulmonary disease—as well as postmenopausal women and immunocompromised individuals, the condition is clinically defined by persistently positive respiratory sputum cultures after at le...

Refractory *Mycobacterium avium* complex pulmonary disease is a chronic, non-tuberculous mycobacterial infection of the respiratory tract that persists despite standard multi-agent antimicrobial therapy

Refractory *Mycobacterium avium* complex pulmonary disease is a chronic, non-tuberculous mycobacterial infection of the respiratory tract that persists despite standard multi-agent antimicrobial therapy Predominantly affecting adults with structural lung abnormalities—such as bronchiectasis or chronic obstructive pulmonary disease—as well as postmenopausal women and immunocompromised individuals, the condition is clinically defined by persistently positive respiratory sputum cultures after at le...

Predominantly affecting adults with structural lung abnormalities—such as bronchiectasis or chronic obstructive pulmonary disease—as well as postmenopausal women and immunocompromised individuals, the condition is clinically defined by persistently positive respiratory sputum cultures after at least six consecutive months of guideline-based treatment

Predominantly affecting adults with structural lung abnormalities—such as bronchiectasis or chronic obstructive pulmonary disease—as well as postmenopausal women and immunocompromised individuals, the condition is clinically defined by persistently positive respiratory sputum cultures after at least six consecutive months of guideline-based treatment Pathophysiologically, it is characterized by chronic granulomatous inflammation, progressive bronchial wall destruction, and parenchymal damage man...

Pathophysiologically, it is characterized by chronic granulomatous inflammation, progressive bronchial wall destruction, and parenchymal damage manifested radiographically as fibrocavitary lesions or nodular bronchiectatic changes

Pathophysiologically, it is characterized by chronic granulomatous inflammation, progressive bronchial wall destruction, and parenchymal damage manifested radiographically as fibrocavitary lesions or nodular bronchiectatic changes Persistent infection often leads to worsening respiratory symptoms, accelerated decline in lung function, and increased mortality